AACR 2024 Annual Meeting-Visit Senhwa Biosciences Exhibit Booth

TAIPEI and SAN DIEGO, April 3, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announces it will be exhibiting at the American Association for Cancer…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks